1. Home
  2. VS vs ARTL Comparison

VS vs ARTL Comparison

Compare VS & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • ARTL
  • Stock Information
  • Founded
  • VS 2013
  • ARTL 2011
  • Country
  • VS United States
  • ARTL United States
  • Employees
  • VS N/A
  • ARTL N/A
  • Industry
  • VS EDP Services
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • VS Technology
  • ARTL Health Care
  • Exchange
  • VS Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • VS 7.0M
  • ARTL 6.7M
  • IPO Year
  • VS N/A
  • ARTL N/A
  • Fundamental
  • Price
  • VS $1.50
  • ARTL $1.72
  • Analyst Decision
  • VS Hold
  • ARTL Buy
  • Analyst Count
  • VS 1
  • ARTL 3
  • Target Price
  • VS $2.00
  • ARTL $30.00
  • AVG Volume (30 Days)
  • VS 12.5K
  • ARTL 532.5K
  • Earning Date
  • VS 11-14-2025
  • ARTL 11-12-2025
  • Dividend Yield
  • VS N/A
  • ARTL N/A
  • EPS Growth
  • VS N/A
  • ARTL N/A
  • EPS
  • VS N/A
  • ARTL N/A
  • Revenue
  • VS $2,179,348.00
  • ARTL N/A
  • Revenue This Year
  • VS $3,459.21
  • ARTL N/A
  • Revenue Next Year
  • VS N/A
  • ARTL N/A
  • P/E Ratio
  • VS N/A
  • ARTL N/A
  • Revenue Growth
  • VS 2281.70
  • ARTL N/A
  • 52 Week Low
  • VS $1.39
  • ARTL $1.55
  • 52 Week High
  • VS $3.79
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • VS 30.46
  • ARTL 27.68
  • Support Level
  • VS $1.41
  • ARTL $1.55
  • Resistance Level
  • VS $1.56
  • ARTL $1.89
  • Average True Range (ATR)
  • VS 0.09
  • ARTL 0.22
  • MACD
  • VS -0.01
  • ARTL 0.08
  • Stochastic Oscillator
  • VS 16.46
  • ARTL 33.14

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: